Researchers analyzed data on three variants of concern and found that viral loads were higher and infection lasted longer for the B.1.1.7 variant. They all were more infectious than the original strain, and transmissibility also depended on population demographics.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved since it first emerged in late 2019. Several mutations of the virus have since been observed, with some variants appearing more infectious than the original strain, which also appear to evade immunity gained by previous infections.
Some of these variants have been labeled as variants of concern (VOC) because of their greater transmissibility and infectiousness. These have also been associated with second and third waves in the infections in many countries, leading to their close monitoring, either by sequencing the complete viral genome or reverse-transcription polymerase chain reaction (RT-PCR).
Some RT-PCR studies have suggested that the VOCs may be causing higher viral loads, but those studies were done only at one-time point. In a new study published on the medRxiv* preprint server, researchers from France report how different variants affect virus kinetics in infections.
Testing virus loads
The researchers used data from RT-PCR tests specific to variants performed between February and April 2021 on SARS-CoV-2 positive samples. They used data from more than 17,000 samples. About 73% of the samples were of the B.1.1.7 variant, 6% of the B.1.351 or P.1 variants, and the rest were wild-type.
A model was developed that included several co-factors, such as the patient’s age, the virus lineage, and whether the patient was hospitalized.
They found that the viral loads were different between the wild-type virus and the different variants. For the B.1.1.7 strain, peak virus load increased with age. The cycle threshold values for the B.1.351 and P.1 strains were slightly lower than that for the wild-type strain, indicating slightly lower viral loads for these variants.
In addition, the rate of decrease of viral load with time was lower for the B.1.1.7 strain compared to the wild-type virus. The data also showed higher peak loads and a lower rate of viral load decrease in hospitalized individuals, about 1.5 days more.
Scientists have worked out how to best get DNA to communicate with membranes in our body, paving the way for the creation of ‘mini biological computers’ in droplets that have potential uses in biosensing [...]
Reactive oxygen species (ROS) exhibit the potential to act as signal carriers during the development of malignant tumors. At a suitable concentration, ROS tends to mediate cell growth and signal transduction. But ROS are [...]
One of the biggest challenges when it comes to probing and manipulating the brain are the blunt tools we have at our disposal. But breakthroughs in nanotechnology could soon change that, say researchers. Neuroscience has [...]
When liquid meets gas, a unique zone forms. Variable by nature, molecules can cross from one state to another, combining in unique ways to either desirable or unwanted ends. From heat escaping a mug [...]
A newly detected coronavirus variant is on the rise in England, with the virus believed to be an offshoot of Delta. According to a briefing from the UK Health Security Agency, released on Friday, [...]
A team of researchers has developed a new nanomechanical technique for fast, one-step, immune-affinity tests, which can quantify the immune response induced by different COVID-19 variants in serum. Their technique provides a new tool [...]
Lawrence Livermore National Laboratory (LLNL) scientists have developed a new method for 3D printing living microbes in controlled patterns, expanding the potential for using engineered bacteria to recover rare-earth metals, clean wastewater, detect uranium, [...]
Nanomedicines may offer clinicians a way to deliver precise, targeted therapy directly to tumors without damaging surrounding tissue. Yet, progress in the development of new drugs that treat cancer at the nanoparticle level has [...]
Cambridge researchers have discovered how T cells—an important component of our immune system—are able keep on killing as they hunt down and kill cancer cells, repeatedly reloading their toxic weapons. Cytotoxic T [...]
Sunday, October 3, set records for the most COVID-19 deaths in Russia on a single day. Only 29% of people in Russia are vaccinated, despite the country being the first to approve a vaccine. [...]
New research from the University of Technology Sydney (UTS) has found that pathogens that form biofilms can evolve to survive nanosilver treatment. The study is the first to demonstrate that long-term nanosilver treatment can [...]
New variants of SARS-CoV-2 are more virulent and transmissible than the original variant of the virus. Health experts associate these variants of concern (VOCs) with increased risk of hospitalization, intensive care unit (ICU) admission, [...]
Freeze-dried genetic circuits could reveal the presence of SARS-CoV-2, Ebola, MRSA, and more. Masks and testing have been key to the COVID-19 pandemic response—and now devices that combine the two may be on the [...]
Hundreds of neuroscientists built a ‘parts list’ of the motor cortex, laying groundwork to map the whole brain and better understand brain diseases. Before you read any further, bring your hand to your forehead. [...]
An international team, led by Swinburne University of Technology and Australian National University (ANU), have made a breakthrough discovery that could potentially lead to faster, more accurate molecular or virus tests, including for COVID-19. [...]